Our Story
For more than 30 years, our primary field of interest has been the development of innovative, patient-centric technology that effectively delivers therapies to patients with Parkinson’s disease. We work with specialist focus groups, fund clinical trials and invest in care initiatives that optimise treatment programmes and improve quality of life.
Our Culture
We continue to redefine and innovate drug delivery methods for Parkinson’s and other disorders, and are committed to combining research and development excellence with world-class patient care, through caring for peoples health as a trusted partner.